Extrait de Myrtille (36 % d'anthocyanosides)(fruits), 250 mg
Extrait de Myrtille (36 % d'anthocyanosides)(fruits), 250 mg, NPN 80016777: natural health product licensed in Canada. Medicinal ingredients: Vaccinium myrtillus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium myrtillus Source : Fruit Extraction ratio : 100:1 Dry plant equivalent : 25,000 mg Potency : 36 % Anthocyanosides | 250 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropylméthylcellulose, Cellulose, microcristalline, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | Not specified |
Uses authorised in Canada
Utilisé en phytothérapie/ herboristerie pour aider à ralentir la progression des maladies de l'oeil telles que la rétinopathie diabétique et hypertensive, et la dégénérescence maculaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No warning text available in the imported data.
Product record
- Licence holder
- Les Entreprises Gamma Force Inc.
- NPN or DIN-HM
- 80016777
- Status
- Inactive licence
- Licence date
- 18 March 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80016777
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Extrait de Myrtille (36 % d'anthocyanosides)(fruits), 250 mg (Les Entreprises Gamma Force Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80016777-extrait-de-myrtille-36-d-anthocyanosides-fruits-250-mg, updated 18 March 2010.